Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease

NeuroImage

Volumn 159, Issue , 2017, Pages 334-345

  O'Callaghan, J ^a   Holmes, H ^a   Powell, N ^a   Wells, J A ^a   Ismail, O ^a   Harrison, I F ^a   Siow, B ^a   Johnson, R ^b   Ahmed, Z ^b   Fisher, A ^b   Meftah, S ^b   O'Neill, M J ^b   Murray, T K ^b   Collins, E C ^b   Shmueli, K ^c   Lythgoe, M F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IRON; MYELIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN MAPPING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; EX VIVO STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HISTOPATHOLOGY; IN VIVO STUDY; MAGNETISM; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; THALAMUS; TISSUE LEVEL; VOXEL BASED MORPHOMETRY; ANIMAL; BRAIN; IMAGE PROCESSING; PATHOLOGY; PROCEDURES; TAUOPATHY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN MAPPING; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; TAUOPATHIES;

EID: 85026880208     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2017.08.003     Document Type: Article

References (82)

1. Acosta-Cabronero, J., Williams, G.B., Cardenas-Blanco, A., Arnold, R.J., Lupson, V., Nestor, P.J., In vivo quantitative susceptibility mapping (qsm) in Alzheimer's disease. PLoS ONE, 8(11), 2013, e81093, 10.1371/journal.pone.0081093.
2. Acosta-Cabronero, J., Betts, M.J., Cardenas-Blanco, A., Yang, S., Nestor, P.J., In vivo mri mapping of brain iron deposition across the adult lifespan. J. Neurosci., 36(2), 2016, 364.
3. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 21:3 (2000), 383–421, 10.1016/S0197-4580(00)00124-X.
4. Argyridis, I., Li, W., Johnson, G.A., Liu, C., Quantitative magnetic susceptibility of the developing mouse brain reveals microstructural changes in the white matter. NeuroImage 88:0 (2014), 134–142, 10.1016/j.neuroimage.2013.11.026.
5. Benveniste, H., Blackband, S., MR microscopy and high resolution small animal MRI: applications in neuroscience research. Prog. Neurobiol. 67:5 (2002), 393–420, 10.1016/S0301-0082(02)00020-5.
6. Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E.V., Adalsteinsson, E., MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. NeuroImage 59:3 (2012), 2625–2635, 10.1016/j.neuroimage.2011.08.077.
7. Biondetti, E., Karsa, A., Thomas, D.L., Shmueli, K., Evaluating the accuracy of susceptibility maps calculated from single-echo versus multi- echo gradient-echo acquisitions. Conference Proceedings: Annual Meeting of the International Society for Magnetic Resonance in Medicine, at Honolulu, HI, US, 2017, 25.
8. Cai, Z., Xiao, M., Oligodendrocytes and Alzheimer's disease. Int. J. Neurosci., 2015, 1–8, 10.3109/00207454.2015.1025778.
9. Cheng, Y.-C.N., Neelavalli, J., Haacke, E.M., Limitations of calculating field distributions and magnetic susceptibilities in mri using a fourier based method. Phys. Med. Biol. 54:5 (2009), 1169–1189, 10.1088/0031-9155/54/5/005 PubMed PMID: PMC2962550.
10. Cherubini, A., Spoletini, I., Péran, P., Luccichenti, G., Di Paola, M., Sancesario, G., et al. A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci. Lett. 469:2 (2010), 214–218, 10.1016/j.neulet.2009.11.077.
11. Chetty, S., Friedman, A.R., Taravosh-Lahn, K., Kirby, E.D., Mirescu, C., Guo, F., et al. Stress and glucocorticoids promote oligodendrogenesis in the adult hippocampus. Mol. Psychiatry 19:12 (2014), 1275–1283, 10.1038/mp.2013.190.
12. Connor, J.R., Snyder, B.S., Beard, J.L., Fine, R.E., Mufson, E.J., Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31:2 (1992), 327–335, 10.1002/jnr.490310214.
13. Deistung, A., Dittrich, E., Sedlacik, J., Rauscher, A., Reichenbach, J.R., ToF-SWI: simultaneous time of flight and fully flow compensated susceptibility weighted imaging. J. Magnetic Reson. Imaging 29:6 (2009), 1478–1484, 10.1002/jmri.21673.
14. Deistung, A., Schäfer, A., Schweser, F., Biedermann, U., Turner, R., Reichenbach, J.R., Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. NeuroImage 65 (2013), 299–314, 10.1016/j.neuroimage.2012.09.055.
15. Deistung, A., Schweser, F., Reichenbach, J.R., Overview of quantitative susceptibility mapping. NMR Biomed., 2016, 10.1002/nbm.3569 n/a-n/a.
16. Dibb, R., Li, W., Cofer, G., Liu, C., Microstructural origins of gadolinium-enhanced susceptibility contrast and anisotropy. Magnetic Reson. Med. 72:6 (2014), 1702–1711, 10.1002/mrm.25082.
17. El Tannir El Tayara, N., Delatour, B., Le Cudennec, C., Guégan, M., Volk, A., Dhenain, M., Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 22:1 (2006), 199–208, 10.1016/j.nbd.2005.10.013.
18. Emma Biondetti, D.L.T., Shmueli, Karin, Application of laplacian-based methods to multi-echo phase data for accurate susceptibility mapping. Int. Soc. Magnetic Reson. Med., 2016, 1547 (Proceedings of the 24th Annual Meeting of the International Society for Magnetic Resonance in Medicine).
19. Feng, W., Neelavalli, J., Haacke, E.M., Catalytic multiecho phase unwrapping scheme (CAMPUS) in multiecho gradient echo imaging: removing phase wraps on a voxel-by-voxel basis. Magnetic Reson. Med. 70:1 (2013), 117–126, 10.1002/mrm.24457.
20. Good, P.F., Perl, D.P., Bierer, L.M., Schmeidler, J., Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31:3 (1992), 286–292, 10.1002/ana.410310310.
21. Gouw, A.A., Seewann, A., Vrenken, H., van der Flier, W.M., Rozemuller, J.M., Barkhof, F., et al. Heterogeneity of White Matter Hyperintensities in Alzheimer's Disease: Post-mortem Quantitative MRI and Neuropathology. 2008-12-01 00:00:00, 2008, 3286–3298.
22. Haacke, E.M., Liu, S., Buch, S., Zheng, W., Wu, D., Ye, Y., Quantitative susceptibility mapping: current status and future directions. Magn. Reson. Imaging 33:1 (2015), 1–25, 10.1016/j.mri.2014.09.004.
23. Hammond, K.E., Lupo, J.M., Xu, D., Metcalf, M., Kelley, D.A.C., Pelletier, D., et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. NeuroImage 39:4 (2008), 1682–1692, 10.1016/j.neuroimage.2007.10.037.
24. Holmes, H.E., Colgan, N., Ismail, O., Ma, D., Powell, N.M., O'Callaghan, J.M., et al. Imaging the accumulation and suppression of tau pathology using multiparametric MRI. Neurobiol. Aging 39 (2016), 184–194, 10.1016/j.neurobiolaging.2015.12.001.
25. Jack, C.R., Garwood, M., Wengenack, T.M., Borowski, B., Curran, G.L., Lin, J., et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magnetic Reson. Med. 52:6 (2004), 1263–1271, 10.1002/mrm.20266.
26. Jack, C.R., Wengenack, T.M., Reyes, D.A., Garwood, M., Curran, G.L., Borowski, B.J., et al. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J. Neurosci. 25:43 (2005), 10041–10048, 10.1523/jneurosci.2588-05.2005.
27. Klohs, J., Deistung, A., Schweser, F., Grandjean, J., Dominietto, M., Waschkies, C., et al. Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J. Cereb. Blood Flow. Metab. 31:12 (2011), 2282–2292.
28. Klohs, J., Politano, I.W., Deistung, A., Grandjean, J., Drewek, A., Dominietto, M., et al. Longitudinal assessment of amyloid pathology in transgenic ArcAβ mice using multi-parametric magnetic resonance imaging. PLoS ONE, 8(6), 2013, e66097, 10.1371/journal.pone.0066097.
29. Lane, C.A., Parker, T.D., Cash, D.M., Macpherson, K., Donnachie, E., Murray-Smith, H., et al. Study protocol: insight 46 – a neuroscience sub-study of the MRC national survey of health and development. BMC Neurol., 17, 2017, 75, 10.1186/s12883-017-0846-x PubMed PMID: PMC5395844.
30. Langkammer, C., Schweser, F., Krebs, N., Deistung, A., Goessler, W., Scheurer, E., et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 62:3 (2012), 1593–1599, 10.1016/j.neuroimage.2012.05.049.
31. Lee, S.P., Falangola, M.F., Nixon, R.A., Duff, K., Helpern, J.A., Visualization of β-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magnetic Reson. Med. 52:3 (2004), 538–544, 10.1002/mrm.20196.
32. Lee, J., Shmueli, K., Kang, B.-T., Yao, B., Fukunaga, M., van Gelderen, P., et al. The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. NeuroImage 59:4 (2012), 3967–3975, 10.1016/j.neuroimage.2011.10.076.
33. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25:4 (2000), 402–405.
34. Liu, C., Susceptibility tensor imaging. Magnetic Reson. Med. Off. J. Soc. Magnetic Reson. Med./Soc. Magnetic Reson. Med. 63:6 (2010), 1471–1477, 10.1002/mrm.22482 PubMed PMID: PMC2990786.
35. Liu, C., Li, W., Johnson, G.A., Wu, B., High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. NeuroImage 56:3 (2011), 930–938.
36. Liu, T., Liu, J., de Rochefort, L., Spincemaille, P., Khalidov, I., Ledoux, J.R., et al. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magnetic Reson. Med. 66:3 (2011), 777–783, 10.1002/mrm.22816.
37. Liu, T., Wisnieff, C., Lou, M., Chen, W., Spincemaille, P., Wang, Y., Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magnetic Reson. Med. 69:2 (2013), 467–476.
38. Liu, C., Li, W., Tong, K.A., Yeom, K.W., Kuzminski, S., Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J. Magnetic Reson. Imaging, 2014, 10.1002/jmri.24768 n/a-n/a.
39. Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., Markesbery, W.R., Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurological Sci. 158:1 (1998), 47–52, 10.1016/S0022-510X(98)00092-6.
40. Luo, J., He, X., Yablonskiy, D.A., Magnetic susceptibility induced white matter MR signal frequency shifts - experimental comparison between lorentzian sphere and generalized lorentzian approaches. Magnetic Reson. Med. Off. J. Soc. Magnetic Reson. Med./Soc. Magnetic Reson. Med. 71:3 (2014), 1251–1263, 10.1002/mrm.24762 PubMed PMID: PMC3748237.
41. Maphis, N., Xu, G., Kokiko-Cochran, O.N., Jiang, S., Cardona, A., Ransohoff, R.M., et al. Reactive Microglia Drive tau Pathology and Contribute to the Spreading of Pathological Tau in the Brain. 2015 2015-03-30 00:00:00.
42. Mesrob, L., Sarazin, M., Hahn-Barma, V., LCd, Souza, Dubois, B., Gallinari, P., et al. DTI and structural mri classification in Alzheimer¡s disease. Adv. Mol. Imaging, 02(02), 2012, 9, 10.4236/ami.2012.22003.
43. Modat, M., Ridgway, G.R., Taylor, Z.A., Lehmann, M., Barnes, J., Hawkes, D.J., et al. Fast free-form deformation using graphics processing units. Comput. Methods Programs Biomed. 98:3 (2010), 278–284, 10.1016/j.cmpb.2009.09.002.
44. Moon, W.-J., Kim, H.-J., Roh, H.G., Choi, J.W., Han, S.-H., Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with alzheimer disease: its possible association with iron accumulation as evidenced by the T2* map. Korean J. Radiol. 13:6 (2012), 674–683.
45. Morales, I., Guzmán-Martínez, L., Cerda-Troncoso, C., Farías, G.A., Maccioni, R.B., Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches. Front. Cell. Neurosci., 8(112), 2014, 10.3389/fncel.2014.00112.
46. Motulsky, H., Analyzing Data with GraphPad Prism: GraphPad Software Incorporated. 1999.
47. Oguz, I., Yaxley, R., Budin, F., Hoogstoel, M., Lee, J., Maltbie, E., et al. Comparison of magnetic resonance imaging in live vs. Post mortem rat brains. PLoS ONE, 8(8), 2013, e71027, 10.1371/journal.pone.0071027.
48. Ourselin, S., Roche, A., Subsol, G., Pennec, X., Ayache, N., Reconstructing a 3D structure from serial histological sections. Image Vis. Comput. 19:1–2 (2001), 25–31, 10.1016/S0262-8856(00)00052-4.
49. Parsey, R.V., Krishnan, K.R.R., Quantitative analysis of T2 signal intensities in Alzheimer's Disease. Psychiatry Res. Neuroimaging 82:3 (1998), 181–185, 10.1016/S0925-4927(98)00018-3.
50. Poorter, J.D., Wagter, C.D., Deene, Y.D., Thomsen, C., Ståhlberg, F., Achten, E., Noninvasive mri thermometry with the proton resonance frequency (PRF) method: in vivo results in human muscle. Magnetic Reson. Med. 33:1 (1995), 74–81, 10.1002/mrm.1910330111.
51. Powell, N., Fully-automated μMRI morphometric phenotyping of the Tc1 mouse model of Down syndrome. (in press) Plos One, 2017, 2016 PONE-D-16-21927R1.
52. Quarantelli, M., MRI/MRS in neuroinflammation: methodology and applications. Clin. Transl. Imaging 3 (2015), 475–489, 10.1007/s40336-015-0142-y PubMed PMID: PMC4679099.
53. Quesson, B., de Zwart, J.A., Moonen, C.T.W., Magnetic resonance temperature imaging for guidance of thermotherapy. J. Magnetic Reson. Imaging 12:4 (2000), 525–533, 10.1002/1522-2586(200010)12:4<525::aid-jmri3>3.0.co;2-v.
54. Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25 (2005), 10637–10647, 10.1523/JNEUROSCI.3279-05.2005 PubMed PMID.
55. Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., et al. Age-Dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25:46 (2005), 10637–10647, 10.1523/jneurosci.3279-05.2005.
56. Rieke, V., Pauly, K.B., MR thermometry. J. Magnetic Reson. imaging JMRI 27:2 (2008), 376–390, 10.1002/jmri.21265 PubMed PMID: PMC2780364.
57. Sahara, N., Perez, P.D., Lin, W.-L., Dickson, D.W., Ren, Y., Zeng, H., et al. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study. Neurobiol. Aging 35:6 (2014), 1364–1374, 10.1016/j.neurobiolaging.2013.12.009.
58. Scheltens, P., Barkhof, F., Leys, D., Wolters, E.C., Ravid, R., Kamphorst, W., Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45:5 (1995), 883–888, 10.1212/wnl.45.5.883.
59. Schweser, F., Deistung, A., Lehr, B.W., Reichenbach, J.R., Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?. NeuroImage 54:4 (2011), 2789–2807, 10.1016/j.neuroimage.2010.10.070.
60. Shepherd, T.M., Thelwall, P.E., Stanisz, G.J., Blackband, S.J., Aldehyde fixative solutions alter the water relaxation and diffusion properties of nervous tissue. Magnetic Reson. Med. 62:1 (2009), 26–34, 10.1002/mrm.21977.
61. Shmueli, K., de Zwart, J.A., van Gelderen, P., Li, T.-Q., Dodd, S.J., Duyn, J.H., Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magnetic Reson. Med. 62:6 (2009), 1510–1522, 10.1002/mrm.22135.
62. Sjöbeck, M., Haglund, M., Englund, E., Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease—a neuropathological study. Int. J. Geriatric Psychiatry 20:10 (2005), 919–926, 10.1002/gps.1384.
63. Sjöbeck, M., Haglund, M., Englund, E., White matter mapping in Alzheimer's disease: a neuropathological study. Neurobiol. Aging 27:5 (2006), 673–680, 10.1016/j.neurobiolaging.2005.03.007.
64. Straub, S., Schneider, T.M., Emmerich, J., Freitag, M.T., Ziener, C.H., Schlemmer, H.-P., et al. Suitable reference tissues for quantitative susceptibility mapping of the brain. Magnetic Reson. Med., 2016, 10.1002/mrm.26369 n/a-n/a.
65. Stüber, C., Morawski, M., Schäfer, A., Labadie, C., Wähnert, M., Leuze, C., et al. Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. NeuroImage 93:Part 1 (2014), 95–106, 10.1016/j.neuroimage.2014.02.026.
66. Sun, H., Wilman, A.H., Quantitative susceptibility mapping using single-shot echo-planar imaging. Magnetic Reson. Med. 73:5 (2015), 1932–1938, 10.1002/mrm.25316.
67. Tustison, N.J., Avants, B.B., Cook, P.A., Zheng, Y., Egan, A., Yushkevich, P.A., et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29:6 (2010), 1310–1320, 10.1109/tmi.2010.2046908.
68. Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N.P., Arredondo, M., et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 126:4 (2013), 541–549, 10.1111/jnc.12244.
69. Walhovd, K.B., Fjell, A.M., Amlien, I., Grambaite, R., Stenset, V., Bjørnerud, A., et al. Multimodal imaging in mild cognitive impairment: metabolism, morphometry and diffusion of the temporal–parietal memory network. NeuroImage 45:1 (2009), 215–223, 10.1016/j.neuroimage.2008.10.053.
70. Wang, Y., Liu, T., Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magnetic Reson. Med. 73:1 (2015), 82–101, 10.1002/mrm.25358.
71. Wang, D.-S., Bennett, D.A., Mufson, E.J., Mattila, P., Cochran, E., Dickson, D.W., Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci. Res. 48:1 (2004), 93–100, 10.1016/j.neures.2003.10.002.
72. Wells, J.A., O'Callaghan, J.M., Holmes, H.E., Powell, N.M., Johnson, R.A., Siow, B., et al. In vivo imaging of tau pathology using multi-parametric quantitative MRI. NeuroImage 111:0 (2015), 369–378, 10.1016/j.neuroimage.2015.02.023.
73. Wengenack, T.M., Reyes, D.A., Curran, G.L., Borowski, B.J., Lin, J., Preboske, G.M., et al. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. NeuroImage 54:1 (2011), 113–122, 10.1016/j.neuroimage.2010.08.033.
74. Wu, B., Li, W., Guidon, A., Liu, C., Whole brain susceptibility mapping using compressed sensing. Magnetic Reson. Med. 67:1 (2012), 137–147, 10.1002/mrm.23000.
75. Wu, D., Liu, S., Buch, S., Ye, Y., Dai, Y., Haacke, E.M., A fully flow-compensated multiecho susceptibility-weighted imaging sequence: the effects of acceleration and background field on flow compensation. Magnetic Reson. Med. 76:2 (2016), 478–489, 10.1002/mrm.25878.
76. Xu, B., Liu, T., Spincemaille, P., Prince, M., Wang, Y., Flow compensated quantitative susceptibility mapping for venous oxygenation imaging. Magnetic Reson. Med. 72:2 (2014), 438–445, 10.1002/mrm.24937.
77. Yang, D., Xie, Z., Stephenson, D., Morton, D., Hicks, C.D., Brown, T.M., et al. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510). NeuroImage 54:4 (2011), 2652–2658, 10.1016/j.neuroimage.2010.10.067.
78. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido Takaomi, C., et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:3 (2007), 337–351, 10.1016/j.neuron.2007.01.010.
79. Zenaro, E., Piacentino, G., Constantin, G., The blood-brain barrier in Alzheimer's disease. Neurobiol. Dis., 2016, 10.1016/j.nbd.2016.07.007.
80. Zhang, J., Jones, M.V., McMahon, M.T., Mori, S., Calabresi, P.A., In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum. Magnetic Reson. Med. 67:3 (2012), 750–759, 10.1002/mrm.23032.
81. Zhao, Y., Wen, J., Cross, A.H., Yablonskiy, D.A., On the relationship between cellular and hemodynamic properties of the human brain cortex throughout adult lifespan. NeuroImage 133 (2016), 417–429, 10.1016/j.neuroimage.2016.03.022.
82. Zhao, Y., Raichle, M.E., Wen, J., Benzinger, T.L., Fagan, A.M., Hassenstab, J., et al. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. NeuroImage 148 (2017), 296–304, 10.1016/j.neuroimage.2016.12.026.